Bone mineral density in children with acute lymphoblastic leukemia.
Hiroto InabaXueyuan CaoAlice Q HanJohn C PanettaKirsten K NessMonika L MetzgerJeffrey E RubnitzRaul C RibeiroJohn T SandlundSima JehaCheng ChengChing-Hon PuiMary V RellingSue C KastePublished in: Cancer (2017)
BMD Z-scores decreased during therapy, especially in patients who had clinical, pharmacokinetic, and genetic risk factors. Early recognition of BMD changes and strategies to optimize bone health are essential. Cancer 2018;124:1025-35. © 2017 American Cancer Society.
Keyphrases
- bone mineral density
- acute lymphoblastic leukemia
- postmenopausal women
- papillary thyroid
- risk factors
- body composition
- squamous cell
- healthcare
- public health
- mental health
- lymph node metastasis
- gene expression
- squamous cell carcinoma
- genome wide
- allogeneic hematopoietic stem cell transplantation
- bone marrow
- dna methylation
- climate change
- risk assessment
- cell therapy
- health information